Tempus Ai, Inc.
A maker of AI-driven precision medicine tools, Tempus runs a platform that analyzes tumor samples and other health data to help doctors personalize cancer, hereditary, and neuropsychiatry care. Its Diagnostics line performs genomic tests, while Data & Applications sells anonymized health insights and trial-matching services to drugmakers. Founded in 2015 by Eric Lefkofsky, it takes its name from the Latin for "time" — a nod to giving patients more of it.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| BAILLIE GIFFORD & CO | 13G/APassive | 5% | 8.65M | May 7, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 27, 2026 |
| ARK Investment Management LLC | 13GPassive | 5.44% | 9.45M | Mar 6, 2026 |
| Catherine D. Wood | 13GPassive | 5.44% | 9.45M | Mar 6, 2026 |
| Eric Paul Lefkofsky | 13G/APassive | 24% | 42.77M | Feb 10, 2026 |
| Blue Media, LLC | 13G/APassive | 11.8% | 21.05M | Feb 10, 2026 |
| Lefkofsky Family 2025 GRAT | 13G/APassive | 5.8% | 10.00M | Feb 10, 2026 |
| Gray Media, LLC | 13G/APassive | 5.2% | 8.97M | Feb 10, 2026 |
| Red Sky Ventures LLC | 13G/APassive | 4.7% | 8.06M | Nov 13, 2025 |
| Kimberly Jo Keywell | 13G/APassive | 4.7% | 8.06M | Nov 13, 2025 |